Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kestra Medical Technologies (KMTS) Net Income towards Common Stockholders (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Net Income towards Common Stockholders for 2 consecutive years, with -$32.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Net Income towards Common Stockholders fell 38.39% to -$32.8 million in Q4 2025 year-over-year; TTM through Oct 2025 was -$138.8 million, a 90.18% decrease, with the full-year FY2025 number at -$126.1 million, down 53.65% from a year prior.
  • Net Income towards Common Stockholders was -$32.8 million for Q4 2025 at Kestra Medical Technologies, down from -$25.8 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of -$3.6 million in Q2 2024 to a low of -$55.3 million in Q2 2025.